Protecting the Vulnerable: A Beacon of Hope for Older Adults Against RSV The story of the RSV vaccines is one of quiet triumph.
Emerging from the shadows of the COVID 19 pandemic, they bring a glimmer of hope to millions of older adults.
For years, respiratory syncytial virus (RSV) has been a silent killer, claiming thousands of lives annually in the US alone. The introduction of two new vaccines against RSV in 2023 marked a significant turning point.